Plus, a beaten-down enterprise play with more than 100% upside potential, a bitcoin miner with a repositioning plan that caught the eye of a Top 1% analyst, and more.
Mar 7, 2026
Oct 17, 2026
•
1 min read
Plus, a Top 2% analyst's call on a fallen biotech leader...
Oct 10, 2026
Plus, a new Alzheimer's play with a brain-shuttle edge...
Oct 3, 2026
Plus, a vaccine maker weeks from its pivotal test....